We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanoarrays Advance Biologic Detection

By Biotechdaily staff writers
Posted on 21 May 2002
New nanoarrays of proteins with features more than 1,000 times smaller than those used in conventional arrays can yield more information more accurately in a shorter period of time. More...
These nanoarrays have more than one million times the density of current commercial microarrays, say the developers.

The new detection technology, developed by researchers at Northwestern University (Evanston, IL, USA), was reported in the online February 7, 2002, issue of Science. The researchers invented a process called Dip-pen Nanolithography to make the nanoarrays, which allowed them to use an atomic force microscope tip as a nano-pen to write out a tiny protein array on a gold surface. With an array of protein dots as small as 100 nanometers in diameter, the gold surface in between the dots was processed to prevent it from absorbing target proteins and disturbing the readings. When an array on a chip was exposed to protein targets in solution, the protein on the substrate bound its complementary proteins. The atomic force microscope then read the chip and recorded a match where a change in height was detected.

Current technology uses arrays of either proteins or DNA on the micrometer level as screening tools for analyzing DNA, protein-protein interactions, cell biology, and drug testing. Miniaturizing these arrays should dramatically improve their capabilities. The researchers say the new arrays could lead to the next generation of proteomic arrays and new methods of diagnosing infectious diseases, including portable devices that could be used in a doctor's office to rapidly screen for diseases or in the field to detect biologic weapons.

"Creating patterns on a submicrometer level is important,” said Chad A. Mirkin, director of Northwestern's Institute for Nanotechnology and a professor of chemistry. "More detailed questions can be asked and answered when working on the nanometer scale. This is a fundamental advance in biorecognition.”



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.